Traditionally, prostate cancer is diagnosed through a combination of digital rectal examination (DRE) and prostate-specific antigen (PSA) blood test, followed by transrectal ultrasound (TRUS) guided sampling. The gene discussed is KLK3; the disease is prostate carcinoma.